Effect of Dual-Task Training on Pediatric Oncology Patients

November 11, 2021 updated by: Emel Taşvuran Horata, Afyonkarahisar Health Sciences University

Evaluation of the Effect of Dual-Task Training on Muscle Strength, Balance, and Gait in Pediatric Oncology Patients

It is known that the treatment of children with cancer has negative effects on cognition, muscle strength, balance, and gait. Therefore, the aim of this study is to evaluate the effects of dual-task training, which is based on the principle of simultaneous performance of cognitive tasks and motor tasks, on muscle strength, balance, and gait.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Detailed Description

With the increase in the incidence of cancer, the number of children who survived cancer is also increasing. Most studies on cancer survivors show that the disease and its treatment have side effects and long-term late effects on the musculoskeletal system, physical function, motor, and cognitive skills. Therefore, the aim of this study is to evaluate the effects of dual-task training, which is based on the principle of simultaneous performance of cognitive tasks and motor tasks, on muscle strength, balance, and gait. This study is planned to be the first study in which dual-task training is applied in children with cancer.

Study Type

Interventional

Enrollment (Anticipated)

21

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

  • Turkey
      • Afyonkarahisar, Turkey, 03030
        • Recruiting
        • Emel Taşvuran Horata
        • Contact:
        • Contact:
        • Principal Investigator:
          • EMEL TAŞVURAN HORATA, PhD
        • Sub-Investigator:
          • Hamide Nur ÇEVİK ÖZDEMİR, PhD
        • Sub-Investigator:
          • İbrahim EKER, PhD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

6 years to 18 years (Child, Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Diagnosed with pediatric cancer and inpatient and outpatient treatment in Hematology-Oncology Clinics for treatment,
  • Able to walk alone without any walking aid,
  • Children aged 6-18 will be included

Exclusion Criteria:

  • Staying in an isolated room or at risk of infection (neutropenic, etc.),
  • Any orthopedic or neurological disorder that may prevent walking;
  • Having any mental disability that will prevent performing a cognitive task,
  • Individuals with malignant hypertension or unstable heart disease (eg, congestive heart failure) will not be included in the study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Children with cancer
The arm of the research will consist of pediatric patients aged 6-18 years who have been diagnosed with cancer in Afyonkarahisar Health Sciences University, Health Application and Research Center, Department of Pediatric Hematology-Oncology Clinics and who come for outpatient treatment.
Other: Dual-task training
Dual-task training includes simultaneous execution of motor and cognitive tasks. The motor tasks in this study will be walking, going up and downstairs, turning, throwing, and holding a ball. Cognitive tasks will be an n-back test, verbal fluency, remembering sequences of numbers, and performing simple summing.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
gait speed
Time Frame: 600 seconds
Gait speed is the time one takes to walk a specified distance on level surfaces over a short distance. It will be recorded in m/s.
600 seconds
balance
Time Frame: 300 seconds
Balance is evaluated with Timed-up and Go Test. The time elapsed during the test is recorded in seconds.
300 seconds
Muscle strength
Time Frame: 600 seconds
Isometric muscle strength will be evaluated with a hand-held dynamometer. It will be recorded in kg.
600 seconds

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Afyonkarahisar Health Sciences University

Investigators

  • Principal Investigator: EMEL TAŞVURAN HORATA, PhD, AFSU

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 15, 2021

Primary Completion (Anticipated)

September 15, 2022

Study Completion (Anticipated)

September 15, 2023

Study Registration Dates

First Submitted

October 31, 2021

First Submitted That Met QC Criteria

November 11, 2021

First Posted (Actual)

November 12, 2021

Study Record Updates

Last Update Posted (Actual)

November 12, 2021

Last Update Submitted That Met QC Criteria

November 11, 2021

Last Verified

November 1, 2021

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • 2020/387

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cancer

Clinical Trials on Dual-task training

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Saint Lucia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe